213 related articles for article (PubMed ID: 9643563)
21. Osteolytic activity of Walker carcinosarcoma 256 is due to parathyroid hormone-related protein (PTHrP).
Scharla SH; Minne HW; Lempert UG; Krieg P; Rappel S; Maurer E; Grohe U; Ziegler R
Horm Metab Res; 1991 Feb; 23(2):66-9. PubMed ID: 1646150
[TBL] [Abstract][Full Text] [Related]
22. Parathyroid hormone-related protein.
Moseley JM; Gillespie MT
Crit Rev Clin Lab Sci; 1995; 32(3):299-343. PubMed ID: 7495499
[TBL] [Abstract][Full Text] [Related]
23. Hypercalcemia in cancer.
Martin TJ; Grill V
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):123-9. PubMed ID: 1525053
[TBL] [Abstract][Full Text] [Related]
24. [Bone hyperresorption in neoplastic diseases. Foreword].
Vinceneux P
Presse Med; 2000 Mar; 29(9):485-6. PubMed ID: 10745941
[No Abstract] [Full Text] [Related]
25. Acute lymphocytic leukemia in adolescence with multiple osteolytic lesions and hypercalcemia mediated by lymphoblast-producing parathyroid hormone-related peptide: a case report and review of the literature.
Shimonodan H; Nagayama J; Nagatoshi Y; Hatanaka M; Takada A; Iguchi H; Oda Y; Okamura J
Pediatr Blood Cancer; 2005 Sep; 45(3):333-9. PubMed ID: 15700250
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
27. [Parathyroid hormone related peptide (PTHrP) and bone metabolism].
Rouffet J; Barlet JP
Arch Physiol Biochem; 1995 Apr; 103(1):3-13. PubMed ID: 8574773
[TBL] [Abstract][Full Text] [Related]
28. Expression of parathyroid hormone-related protein (PTHrP) in multiple myeloma.
Kitazawa R; Kitazawa S; Kajimoto K; Sowa H; Sugimoto T; Matsui T; Chihara K; Maeda S
Pathol Int; 2002 Jan; 52(1):63-8. PubMed ID: 11940209
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia in a patient with B-cell acute lymphoblastic leukemia: a role of proinflammatory cytokine.
Fukasawa H; Kato A; Fujigaki Y; Yonemura K; Furuya R; Hishida A
Am J Med Sci; 2001 Aug; 322(2):109-12. PubMed ID: 11523624
[TBL] [Abstract][Full Text] [Related]
31. Parathyroid-hormone-related-protein-associated hypercalcemia in a patient with CLL-type low-grade leukemic B-cell lymphoma.
Schöttker B; Heinz W; Weissinger F; Sözener K; Eck M; Seufert J
Haematologica; 2006 Dec; 91(12 Suppl):ECR45. PubMed ID: 17194651
[TBL] [Abstract][Full Text] [Related]
32. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
33. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
Insogna KL
Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
[TBL] [Abstract][Full Text] [Related]
34. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
35. Overview of hypercalcemia of malignancy.
Solimando DA
Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
[TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia in breast cancer.
Francini G; Petrioli R; Maioli E; Gonnelli S; Marsili S; Aquino A; Bruni S
Clin Exp Metastasis; 1993 Sep; 11(5):359-67. PubMed ID: 8375111
[TBL] [Abstract][Full Text] [Related]
38. [Cytokines in bone diseases. Cytokines and malignancy-associated hypercalcemia].
Okazaki R
Clin Calcium; 2010 Oct; 20(10):1497-502. PubMed ID: 20890031
[TBL] [Abstract][Full Text] [Related]
39. Hypercalcemia in breast cancer: an echo of bone mobilization during lactation?
DeMauro S; Wysolmerski J
J Mammary Gland Biol Neoplasia; 2005 Apr; 10(2):157-67. PubMed ID: 16025222
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
